今天是:   返回主页   |   加入收藏   |   联系我们
引用本文:
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  下载PDF阅读器  关闭
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1249次   下载 1353 本文二维码信息
码上扫一扫!
分享到: 微信 更多
黄芩素对胰腺导管腺癌作用机制的研究进展
张梦莹1,2, 王毓睿1,2, 周昆1, 彭雁飞2, 李文华3, 孙力康2
1.天津中医药大学中医药研究院, 天津 301617;2.天津中医药大学中西医结合学院, 天津 301617;3.西藏民族大学医学部, 咸阳 712082
摘要:
胰腺癌是一种病死率极高的消化道恶性肿瘤,约90%为胰腺导管腺癌,和其他肿瘤一样,胰腺癌的侵袭转移是肿瘤患者死亡的主要原因。目前,由于临床上早期诊断困难,胰腺癌患者手术治疗的机率相较于其他消化道肿瘤低,化学治疗是继手术治疗后中晚期胰腺癌的主要治疗手段。由于化学治疗的不良反应逐渐增多,有必要寻求疗效好、毒副反应小的治疗方法和药物。中药以其药物来源广泛、临床应用历史悠久、多靶点协同作用等优点正成为抗肿瘤药物研究的热点。黄芩作为许多中药治疗胰腺癌的方剂配伍药材之一受到研究者的关注。黄芩素是主要来源于黄芩的黄酮类化合物,是目前证实的黄芩中具有抗炎、抗肿瘤活性的主要成分之一。文章对黄芩素在胰腺癌以及其他多种消化道肿瘤中抗肿瘤活性的研究现状及相关的作用及机制进行分析归纳,对黄芩、黄芩素的药物开发前景提出展望。
关键词:  胰腺癌  中药  黄芩素
DOI:10.11656/j.issn.1673-9043.2020.03.21
分类号:R735.9
基金项目:天津中医药大学十二五13学科师资其它科研项目;西藏自治区自然科学基金重点项目[XZ2017ZRG-67(Z)]。
Research progress in the mechanism of baicalein on pancreatic ductal adenocarcinoma
ZHANG Mengying1,2, WANG Yurui1,2, ZHOU Kun1, PENG Yanfei2, LI Wenhua3, SUN Likang2
1.Chinese Medicine Research Institute, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;2.School of Integrative Medicine of Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;3.Department of Medicine, Tibet University for Nationalities, Xianyang 712082, China
Abstract:
Pancreatic cancer is a kind of digestive tract cancer with high mortality,about 90% of which is pancreatic ductal adenocarcinoma. Like other cancers,the invasion and metastasis of pancreatic cancer is the main cause of death of cancer patients. At present,because of the difficulty in early diagnosis,the probability of surgical treatment of pancreatic cancer is lower than that of other digestive tract tumors. Chemical treatment is the main treatment after surgical treatment for advanced pancreatic cancer. As the side effects of chemotherapy are increasing,it is necessary to find a treatment method and drug with good effect and small side effects. Traditional Chinese medicine (TCM) has become a hot spot in the research of anti-tumor drugs because of its wide sources,long history of clinical application and multi-target synergistic effect. Scutellaria baicalensis Georgi,as one of the compatibility of many traditional Chinese medicine prescriptions for the treatment of pancreatic cancer,has attracted the attention of researchers. Scutellarin is a kind of flavonoid derived from Scutellaria baicalensis Georgi. It is one of the main components with anti-inflammatory and anti-tumor activities in Scutellaria baicalensis Georgi. In this paper,the anti-tumor activity of baicalein in pancreatic cancer and other digestive tract tumors was analyzed and summarized,and the prospect of drug development of Scutellaria baicalensis Georgi and baicalein was put forward.
Key words:  pancreatic cancer  traditional Chinese medicine  baicalein
关注公众号二维码